135 related articles for article (PubMed ID: 23253383)
1. HDAC2 as a new target to improve schizophrenia treatment.
Kurita M; Holloway T; González-Maeso J
Expert Rev Neurother; 2013 Jan; 13(1):1-3. PubMed ID: 23253383
[No Abstract] [Full Text] [Related]
2. HDAC2-dependent Antipsychotic-like Effects of Chronic Treatment with the HDAC Inhibitor SAHA in Mice.
de la Fuente Revenga M; Ibi D; Saunders JM; Cuddy T; Ijaz MK; Toneatti R; Kurita M; Holloway T; Shen L; Seto J; Dozmorov MG; González-Maeso J
Neuroscience; 2018 Sep; 388():102-117. PubMed ID: 30025863
[TBL] [Abstract][Full Text] [Related]
3. Catechol-O-methyl transferase as a drug target for schizophrenia.
O'Tuathaigh CM; Desbonnet L; Lee P; Waddington JL
CNS Neurol Disord Drug Targets; 2012 May; 11(3):282-91. PubMed ID: 22483298
[TBL] [Abstract][Full Text] [Related]
4. Antipsychotic-induced Hdac2 transcription via NF-κB leads to synaptic and cognitive side effects.
Ibi D; de la Fuente Revenga M; Kezunovic N; Muguruza C; Saunders JM; Gaitonde SA; Moreno JL; Ijaz MK; Santosh V; Kozlenkov A; Holloway T; Seto J; García-Bea A; Kurita M; Mosley GE; Jiang Y; Christoffel DJ; Callado LF; Russo SJ; Dracheva S; López-Giménez JF; Ge Y; Escalante CR; Meana JJ; Akbarian S; Huntley GW; González-Maeso J
Nat Neurosci; 2017 Sep; 20(9):1247-1259. PubMed ID: 28783139
[TBL] [Abstract][Full Text] [Related]
5. Expression of HDAC2 but Not HDAC1 Transcript Is Reduced in Dorsolateral Prefrontal Cortex of Patients with Schizophrenia.
Schroeder FA; Gilbert TM; Feng N; Taillon BD; Volkow ND; Innis RB; Hooker JM; Lipska BK
ACS Chem Neurosci; 2017 Mar; 8(3):662-668. PubMed ID: 27959513
[TBL] [Abstract][Full Text] [Related]
6. Comments on 'The effect of risperidone on D-amino acid oxidase activity as a hypothesis for a novel mechanism of action in the treatment of schizophrenia'.
Hashimoto K
J Psychopharmacol; 2010 Jul; 24(7):1133-4. PubMed ID: 19939869
[No Abstract] [Full Text] [Related]
7. Opening a New Time Window for Treatment of Stroke by Targeting HDAC2.
Lin YH; Dong J; Tang Y; Ni HY; Zhang Y; Su P; Liang HY; Yao MC; Yuan HJ; Wang DL; Chang L; Wu HY; Luo CX; Zhu DY
J Neurosci; 2017 Jul; 37(28):6712-6728. PubMed ID: 28592694
[TBL] [Abstract][Full Text] [Related]
8. Coordination of PAD4 and HDAC2 in the regulation of p53-target gene expression.
Li P; Wang D; Yao H; Doret P; Hao G; Shen Q; Qiu H; Zhang X; Wang Y; Chen G; Wang Y
Oncogene; 2010 May; 29(21):3153-62. PubMed ID: 20190809
[TBL] [Abstract][Full Text] [Related]
9. Inhibiting Histone Deacetylase 2 (HDAC2) Promotes Functional Recovery From Stroke.
Tang Y; Lin YH; Ni HY; Dong J; Yuan HJ; Zhang Y; Liang HY; Yao MC; Zhou QG; Wu HY; Chang L; Luo CX; Zhu DY
J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 28982677
[TBL] [Abstract][Full Text] [Related]
10. DeltaNp63, a target of DEC1 and histone deacetylase 2, modulates the efficacy of histone deacetylase inhibitors in growth suppression and keratinocyte differentiation.
Qian Y; Jung YS; Chen X
J Biol Chem; 2011 Apr; 286(14):12033-41. PubMed ID: 21317427
[TBL] [Abstract][Full Text] [Related]
11. Detection of Sumo Modification of Endogenous Histone Deacetylase 2 (HDAC2) in Mammalian Cells.
Citro S; Chiocca S
Methods Mol Biol; 2016; 1436():15-22. PubMed ID: 27246205
[TBL] [Abstract][Full Text] [Related]
12. Design of Potent Panobinostat Histone Deacetylase Inhibitor Derivatives: Molecular Considerations for Enhanced Isozyme Selectivity between HDAC2 and HDAC8.
Stoddard SV; May XA; Rivas F; Dodson K; Vijayan S; Adhika S; Parker K; Watkins DL
Mol Inform; 2019 Mar; 38(3):e1800080. PubMed ID: 30369061
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-223 controls the expression of histone deacetylase 2: a novel axis in COPD.
Leuenberger C; Schuoler C; Bye H; Mignan C; Rechsteiner T; Hillinger S; Opitz I; Marsland B; Faiz A; Hiemstra PS; Timens W; Camici GG; Kohler M; Huber LC; Brock M
J Mol Med (Berl); 2016 Jun; 94(6):725-34. PubMed ID: 26864305
[TBL] [Abstract][Full Text] [Related]
14. E3 ligase RCHY1 negatively regulates HDAC2.
Choi M; Choi YM; An IS; Bae S; Jung JH; An S
Biochem Biophys Res Commun; 2020 Jan; 521(1):37-41. PubMed ID: 31630802
[TBL] [Abstract][Full Text] [Related]
15. Valproic acid (VPA) reduces sensorimotor gating deficits and HDAC2 overexpression in the MAM animal model of schizophrenia.
Bator E; Latusz J; Radaszkiewicz A; Wędzony K; Maćkowiak M
Pharmacol Rep; 2015 Dec; 67(6):1124-9. PubMed ID: 26481530
[TBL] [Abstract][Full Text] [Related]
16. Nucleolar Translocation of Histone Deacetylase 2 Is Involved in Regulation of Transcriptional Silencing in the Cat Germinal Vesicle.
Lee PC; Wildt DE; Comizzoli P
Biol Reprod; 2015 Aug; 93(2):33. PubMed ID: 26108793
[TBL] [Abstract][Full Text] [Related]
17. Trans-regulation of histone deacetylase activities through acetylation.
Luo Y; Jian W; Stavreva D; Fu X; Hager G; Bungert J; Huang S; Qiu Y
J Biol Chem; 2009 Dec; 284(50):34901-10. PubMed ID: 19822520
[TBL] [Abstract][Full Text] [Related]
18. Histone Deacetylase 2 (HDAC2) Inhibitors Containing Boron.
Kavianpour P; Gemmell MCM; Kahlert JU; Rendina LM
Chembiochem; 2020 Oct; 21(19):2786-2791. PubMed ID: 32367603
[TBL] [Abstract][Full Text] [Related]
19. 1,25(OH)
Huang J; Yang G; Huang Y; Zhang S
Biochimie; 2018 Mar; 146():28-34. PubMed ID: 29158005
[TBL] [Abstract][Full Text] [Related]
20. Effects of alcohol on histone deacetylase 2 (HDAC2) and the neuroprotective role of trichostatin A (TSA).
Agudelo M; Gandhi N; Saiyed Z; Pichili V; Thangavel S; Khatavkar P; Yndart-Arias A; Nair M
Alcohol Clin Exp Res; 2011 Aug; 35(8):1550-6. PubMed ID: 21447001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
